Setting up of Indian national authority on drugs and therapeutics

Posted AtRxpgnews.com

The Indian Task Force under the Chairmanship of Dr. Pronab Sen, Principal Advisor , Planning Commission has recommended, inter-alia, to establish a National Authority on Drugs and Therapeutics (NADT) as a long term objective. This would integrate the offices of the Drug Controller General (India), the Central Drugs Standard Control Organization (CDSCO) and the National Pharmaceutical Pricing Authority (NPPA) along with all the powers and functions of these bodies.

The Government in consultation with various Stake-holders is examining the recommendations of the Task Force. Based on this a view would be taken regarding the setting up of the National Authority on Drugs and Therapeutics.

This information was given by the Minister of Chemicals & Fertilizers and Steel, Shri Ram Vilas Paswan in a written reply to a question in the Lok Sabha .

LOK SABHA

The Confederation of Indian Industry (CII) has made some projections for the performance of pharmaceutical industry for years ahead through reports/studies such as India Brand Equity Foundation (IBEF) report and CII – KPMG Consultations study on Vision for Pharmaceuticals.

As per the report of IBEF, the pharmaceutical sector is expected to attain a size of US $ 25 billion by 2010 and Indian Companies can potentially corner almost a third of the global generics market by 2007.

Similarly, as per the CII-KPMG Consultants study, Indian domestic market is expected to grow from US $ 6 billion at present to US $ 9 billion by 2010 and Indian generic drug makers are expected to have 38 % share in global generics market by 2007 compared to 4 % at present.

This information was given by the Minister of Chemicals & Fertilizers and Steel, Shri Ram Vilas Paswan in a written reply to a question in the Lok Sabha

December 12, 2005